ASCO 2022 Esophageal Cancer Question & Answer

Joseph Chao, MD, from City of Hope, Question and Answer Session on Esophageal Cancer


Question and Answer Session

Joseph Chao, MD - ASCO 2022 Esophageal In-Depth Slides: MOASC Spotlight

Joseph Chao, MD - About The Author, Credentials, and Affiliations

Joseph Chao, MD, one of Pasadena magazine's "Top Doctors" for oncology since 2011, joined the City of Hope as a resident of oncology in 2007 and was appointed as an assistant professor with a specialty in stomach and esophageal (gastric cancer) malignancies in 2010.


Currently, he is heading clinical trial efforts to find novel therapeutics for gastroesophageal malignancies and undertaking studies to gain a better understanding of intratumoral heterogeneity in this illness.


The NIH Paul Calabresi Career Creation Award in Clinical Oncology recognizes his ongoing work in immunotherapeutics and the development of new biomarkers for gastric cancer.


Dr. Chao serves on the National Comprehensive Cancer Network (NCCN) panels for Gastric and Esophageal Cancer(s) and is the current academic co-chair for Elsevier/Via Oncology Pathways in gastroesophageal malignancies in clinical oncology.


His knowledge has helped develop national treatment guidelines. Dr. Chao received his medical degree from the University of Illinois at Chicago before continuing his education at Harbor-UCLA Medical Center.